We are live on ! Find out more
FFVM

Founders Fund VII Management Portfolio holdings

AUM $2.03M
1-Year Est. Return 72.34%
This Fund
S&P 500
This Quarter Est. Return
-21.53%
1 Year Est. Return
+72.34%
3 Year Est. Return
-64.66%
5 Year Est. Return
-90.66%
10 Year Est. Return
AUM
$178M
AUM Growth
Cap. Flow
+$196M
Cap. Flow %
110.05%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
ABCL icon
AbCellera Biologics
ABCL
+$173M
2
CMPS
Compass Pathways
CMPS
+$23.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCL icon
1
AbCellera Biologics
ABCL
$3.99B
$152M 85.11%
+3,773,530
New +$173M
CMPS
2
Compass Pathways
CMPS
$2.05B
$26.6M 14.89%
+557,760
New +$23.8M

Similar funds

Founders Fund VII Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Founders Fund VII Management, which disclosed 2 positions worth $178M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is AbCellera Biologics: 3,773,530 shares worth $152M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Founders Fund VII Management's largest Q4 2020 buy was AbCellera Biologics: 3,773,530 shares worth $152M.
  • Founders Fund VII Management's ten largest holdings make up 100% of its $178M portfolio in Q4 2020.
  • Founders Fund VII Management disclosed 2 positions in Q4 2020, its first 13F filing on record.

Based on Founders Fund VII Management's 13F filing for Q4 2020, filed 16 Feb 2021.